• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS B 101 HBA1C TEST; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS B 101 HBA1C TEST; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Catalog Number 08038694190
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/01/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The customer does not have any more reagent discs to return.
 
Event Description
The customer complained of discrepant results for 1 patient tested for cobas hba1c test (hba1c) on a cobas b 101 system.The date of event was either (b)(6) 2018.Clarification on the correct date has been requested but not yet provided.The patient was tested on the b 101 system at approximately 11:30 a.M.And the result was 11.8% (106 mmol/mol).Blood was drawn for a laboratory test on the same day and the result from the bio-rad d-100 method was 13.5% (124 mmol/mol).There was no allegation that an adverse event occurred.The b 101 instrument serial number was (b)(4).Qc results were acceptable.The bio-rad method is an ion exchange high performance liquid chromatography test.The b 101 system and the d-100 bio-rad method do not use the same reference method.Systems using different reference methods can produce different results.The customer does not have any reagent discs from the hba1c lot number complained about to return.Retention material lot number 816041 was tested on a retention cobas b 101 instrument.All the results obtained were within the specification.No discrepancies or incorrect results were observed with the retention material.
 
Manufacturer Narrative
The date of event was clarified to be (b)(6) 2018.
 
Manufacturer Narrative
The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS B 101 HBA1C TEST
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7865519
MDR Text Key119943677
Report Number1823260-2018-03068
Device Sequence Number1
Product Code LCP
UDI-Device Identifier07613336119778
UDI-Public7613336119778
Combination Product (y/n)N
PMA/PMN Number
K163633
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 09/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/11/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08038694190
Device Lot Number816041
Was Device Available for Evaluation? No
Date Manufacturer Received08/22/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
UNSPECIFIED INSULIN
Patient Age42 YR
Patient Weight90
-
-